Literature DB >> 9334643

Lack of distant migration after injection of a 125iodine labeled dextranomer based implant into the rabbit bladder.

A M Stenberg1, A Sundin, B S Larsson, G Läckgren, A Stenberg.   

Abstract

PURPOSE: In recent years endoscopic treatment of stress incontinence and vesicoureteral reflux has been introduced. Reports of possible particle migration of the injected material to distant organs in humans and experimental animals have led to a search for biological nonmigration products. An implant found to have a good clinical effect in these conditions is dextranomer in hyaluronan. We performed this study in rabbits to investigate the possible migration of dextranomer particles.
MATERIALS AND METHODS: 125Iodine labeled dextranomer particles were injected into the submucosal space of rabbit bladders, and samples of blood and various tissues were examined for radioactivity at scheduled intervals during a 28-day period. Furthermore, whole body autoradiography was performed 1 day, and 1 and 4 weeks after injection.
RESULTS: Radioactivity was found in blood samples and in all tissues but it remained at the background activity level except in the thyroid, where uptake representing free 125iodine was detected. In the bladder 41 and 45% of the injected dose remained within the bladder wall 1 day and 4 weeks, respectively, after injection. The remainder of the dose probably disappeared from the bladder wall by leakage into the urine shortly after deposition, as indicated by the finding of 10-fold higher urine radioactivity levels at day 1 than at day 28 after injection.
CONCLUSIONS: No distant migration of dextranomer particles occurs after submucosal injection of such an implant in the rabbit bladder wall.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9334643     DOI: 10.1016/s0022-5347(01)64185-5

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  29 in total

Review 1.  [New techniques for surgical treatment of postoperative male stress incontinence].

Authors:  S Bross; S T Kwon; S Peter; P Honeck
Journal:  Urologe A       Date:  2007-03       Impact factor: 0.639

2.  Periurethral granuloma following injection with dextranomer/hyaluronic acid copolymer for stress urinary incontinence.

Authors:  María-Teresa Castillo-Vico; Miguel A Checa-Vizcaíno; Antonio Payà-Panadés; Carolina Rueda-García; Ramón Carreras-Collado
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-12-03

3.  Endoscopic treatment of vesicoureteral reflux: current practice and the need for multifactorial assessment.

Authors:  Göran Läckgren; Arne Stenberg
Journal:  Ther Adv Urol       Date:  2009-08

4.  The treatment of vesicoureteral reflux in children by endoscopic sub-mucosal intra-ureteral injection of dextranomer/hyaluronic acid: A case-series, multi-centre study.

Authors:  Osama Bawazir
Journal:  Electron Physician       Date:  2017-04-25

5.  Histological response to injected dextranomer-based implant in a rat model.

Authors:  Murat Alkan; Arbay O Ciftci; Beril Talim; Mehmet E Senocak; Melda Caglar; Nebil Buyukpamukcu
Journal:  Pediatr Surg Int       Date:  2006-10-17       Impact factor: 1.827

6.  Comparison of histopathological characteristics of polyacrylate polyalcohol copolymer with dextranomer/hyaluronic acid after injection beneath the bladder mucosa layer: a rabbit model.

Authors:  Abdol-Mohammad Kajbafzadeh; Shabnam Sabetkish; Reza Khorramirouz; Nastaran Sabetkish
Journal:  Int Urol Nephrol       Date:  2017-02-16       Impact factor: 2.370

7.  Factors that impact the outcome of endoscopic correction of vesicoureteral reflux: a multivariate analysis.

Authors:  Abdol-Mohammad Kajbafzadeh; Ali Tourchi; Zahra Aryan
Journal:  Int Urol Nephrol       Date:  2012-11-17       Impact factor: 2.370

Review 8.  Diagnosis and management of vesicoureteral reflux in children.

Authors:  Christopher S Cooper
Journal:  Nat Rev Urol       Date:  2009-08-11       Impact factor: 14.432

9.  Efficacy of dextranomer hyaluronic acid and polyacrylamide hydrogel in endoscopic treatment of vesicoureteral reflux: A comparative study.

Authors:  Anne-Sophie Blais; Fannie Morin; Jonathan Cloutier; Katherine Moore; Stéphane Bolduc
Journal:  Can Urol Assoc J       Date:  2015 May-Jun       Impact factor: 1.862

10.  Endoscopic treatment of vesicoureteric reflux with Deflux: a Canadian experience.

Authors:  Luis A Guerra; Priya Khanna; Michele Levasseur; John G Pike; Michael P Leonard
Journal:  Can Urol Assoc J       Date:  2007-03       Impact factor: 1.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.